COVID-19 pandemic in China: Context, experience and lessons.
Identifieur interne : 001890 ( Main/Corpus ); précédent : 001889; suivant : 001891COVID-19 pandemic in China: Context, experience and lessons.
Auteurs : Weiwei Xu ; Jing Wu ; Lidan CaoSource :
- Health policy and technology [ 2211-8837 ] ; 2020.
Abstract
The first cluster of COVID-19 cases was reported in Wuhan, China on December 29th, 2019. Since then, China has experienced a pandemic of COVID-19.
OBJECTIVE
This study aims to present the context in which the pandemic has evolved, the government's response and the pandemic's impact on public health and national economy.
METHODS
A review was conducted to collect relevant data from press releases and government reports.
RESULTS
COVID-19 poses a major public health threat on China with a cumulative number of cases over 89,000 (data cut-off date: August 9th, 2020). Between January and February 2020, China implemented a series of escalating policies (including a stringent nation-wide lockdown) to combat the pandemic. Therefore, it has been to a large extent limited to the Wuhan region. Social media such as WeChat and SinaWeibo played a crucial role in disseminating government information and public campaigns during the pandemic. Technologies were adopted to enable contact tracing and population travel patterns. The Chinese central government mobilized healthcare resources including healthcare personnel and medical materials to Wuhan in a highly effective way. Both central and regional governments launched financial policies to stimulate the economy, including special loans, tax extension, reduction or waiver. Nevertheless, the economy in China was significantly impacted especially during the lockdown period.
CONCLUSIONS
China has responded to the COVID-19 epidemic in a highly centralized and effective way. Balancing the needs to prevent a future pandemic and to boost economic recovery remains a challenge.
DOI: 10.1016/j.hlpt.2020.08.006
PubMed: 32874851
PubMed Central: PMC7451009
Links to Exploration step
pubmed:32874851Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 pandemic in China: Context, experience and lessons.</title><author><name sortKey="Xu, Weiwei" sort="Xu, Weiwei" uniqKey="Xu W" first="Weiwei" last="Xu">Weiwei Xu</name><affiliation><nlm:affiliation>GongJing Healthcare Ltd., China.</nlm:affiliation></affiliation></author><author><name sortKey="Wu, Jing" sort="Wu, Jing" uniqKey="Wu J" first="Jing" last="Wu">Jing Wu</name><affiliation><nlm:affiliation>School of Pharmaceutical Science and Technology, Tianjin University, China.</nlm:affiliation></affiliation></author><author><name sortKey="Cao, Lidan" sort="Cao, Lidan" uniqKey="Cao L" first="Lidan" last="Cao">Lidan Cao</name><affiliation><nlm:affiliation>School of Pharmaceutical Science and Technology, Tianjin University, China.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32874851</idno><idno type="pmid">32874851</idno><idno type="doi">10.1016/j.hlpt.2020.08.006</idno><idno type="pmc">PMC7451009</idno><idno type="wicri:Area/Main/Corpus">001890</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001890</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 pandemic in China: Context, experience and lessons.</title><author><name sortKey="Xu, Weiwei" sort="Xu, Weiwei" uniqKey="Xu W" first="Weiwei" last="Xu">Weiwei Xu</name><affiliation><nlm:affiliation>GongJing Healthcare Ltd., China.</nlm:affiliation></affiliation></author><author><name sortKey="Wu, Jing" sort="Wu, Jing" uniqKey="Wu J" first="Jing" last="Wu">Jing Wu</name><affiliation><nlm:affiliation>School of Pharmaceutical Science and Technology, Tianjin University, China.</nlm:affiliation></affiliation></author><author><name sortKey="Cao, Lidan" sort="Cao, Lidan" uniqKey="Cao L" first="Lidan" last="Cao">Lidan Cao</name><affiliation><nlm:affiliation>School of Pharmaceutical Science and Technology, Tianjin University, China.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Health policy and technology</title><idno type="ISSN">2211-8837</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The first cluster of COVID-19 cases was reported in Wuhan, China on December 29th, 2019. Since then, China has experienced a pandemic of COVID-19.</div><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>This study aims to present the context in which the pandemic has evolved, the government's response and the pandemic's impact on public health and national economy.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>A review was conducted to collect relevant data from press releases and government reports.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>COVID-19 poses a major public health threat on China with a cumulative number of cases over 89,000 (data cut-off date: August 9th, 2020). Between January and February 2020, China implemented a series of escalating policies (including a stringent nation-wide lockdown) to combat the pandemic. Therefore, it has been to a large extent limited to the Wuhan region. Social media such as WeChat and SinaWeibo played a crucial role in disseminating government information and public campaigns during the pandemic. Technologies were adopted to enable contact tracing and population travel patterns. The Chinese central government mobilized healthcare resources including healthcare personnel and medical materials to Wuhan in a highly effective way. Both central and regional governments launched financial policies to stimulate the economy, including special loans, tax extension, reduction or waiver. Nevertheless, the economy in China was significantly impacted especially during the lockdown period.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>China has responded to the COVID-19 epidemic in a highly centralized and effective way. Balancing the needs to prevent a future pandemic and to boost economic recovery remains a challenge.</p></div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32874851</PMID><DateRevised><Year>2020</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2211-8837</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Health policy and technology</Title><ISOAbbreviation>Health Policy Technol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 pandemic in China: Context, experience and lessons.</ArticleTitle><Pagination><MedlinePgn>639-648</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hlpt.2020.08.006</ELocationID><Abstract><AbstractText>The first cluster of COVID-19 cases was reported in Wuhan, China on December 29th, 2019. Since then, China has experienced a pandemic of COVID-19.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to present the context in which the pandemic has evolved, the government's response and the pandemic's impact on public health and national economy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A review was conducted to collect relevant data from press releases and government reports.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">COVID-19 poses a major public health threat on China with a cumulative number of cases over 89,000 (data cut-off date: August 9th, 2020). Between January and February 2020, China implemented a series of escalating policies (including a stringent nation-wide lockdown) to combat the pandemic. Therefore, it has been to a large extent limited to the Wuhan region. Social media such as WeChat and SinaWeibo played a crucial role in disseminating government information and public campaigns during the pandemic. Technologies were adopted to enable contact tracing and population travel patterns. The Chinese central government mobilized healthcare resources including healthcare personnel and medical materials to Wuhan in a highly effective way. Both central and regional governments launched financial policies to stimulate the economy, including special loans, tax extension, reduction or waiver. Nevertheless, the economy in China was significantly impacted especially during the lockdown period.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">China has responded to the COVID-19 epidemic in a highly centralized and effective way. Balancing the needs to prevent a future pandemic and to boost economic recovery remains a challenge.</AbstractText><CopyrightInformation>© 2020 Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>GongJing Healthcare Ltd., China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Lidan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Health Policy Technol</MedlineTA><NlmUniqueID>101597449</NlmUniqueID><ISSNLinking>2211-8837</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">Impact</Keyword><Keyword MajorTopicYN="N">Policy</Keyword><Keyword MajorTopicYN="N">Technology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32874851</ArticleId><ArticleId IdType="doi">10.1016/j.hlpt.2020.08.006</ArticleId><ArticleId IdType="pii">S2211-8837(20)30078-2</ArticleId><ArticleId IdType="pmc">PMC7451009</ArticleId></ArticleIdList><pmc-dir>pmcsd</pmc-dir>
<ReferenceList><Reference><Citation>Lancet Public Health. 2020 May;5(5):e261-e270</Citation><ArticleIdList><ArticleId IdType="pubmed">32220655</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Netw Open. 2020 May 1;3(5):e208297</Citation><ArticleIdList><ArticleId IdType="pubmed">32374400</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Pediatr. 2020 Apr;87(4):281-286</Citation><ArticleIdList><ArticleId IdType="pubmed">32166607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2019 Aug 3;394(10196):364-366</Citation><ArticleIdList><ArticleId IdType="pubmed">31230827</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorac Cancer. 2019 Jan;10(1):3-7</Citation><ArticleIdList><ArticleId IdType="pubmed">30485694</ArticleId></ArticleIdList></Reference><Reference><Citation>Transl Lung Cancer Res. 2019 May;8(Suppl 1):S21-S30</Citation><ArticleIdList><ArticleId IdType="pubmed">31211103</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Psychiatry Psychiatr Epidemiol. 2016 Apr;51(4):513-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26724945</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2018 Jun;6(6):421-430</Citation><ArticleIdList><ArticleId IdType="pubmed">29650407</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Mar 26;382(13):1199-1207</Citation><ArticleIdList><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151</Citation><ArticleIdList><ArticleId IdType="pubmed">32064853</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2020 Mar 31;24(1):124</Citation><ArticleIdList><ArticleId IdType="pubmed">32234064</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001890 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001890 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= LockdownV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32874851
|texte= COVID-19 pandemic in China: Context, experience and lessons.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32874851" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LockdownV1
| This area was generated with Dilib version V0.6.38. |  |